全文获取类型
收费全文 | 63556篇 |
免费 | 3092篇 |
国内免费 | 277篇 |
专业分类
耳鼻咽喉 | 854篇 |
儿科学 | 1737篇 |
妇产科学 | 1508篇 |
基础医学 | 8447篇 |
口腔科学 | 1569篇 |
临床医学 | 4690篇 |
内科学 | 15979篇 |
皮肤病学 | 1358篇 |
神经病学 | 5574篇 |
特种医学 | 2134篇 |
外国民族医学 | 6篇 |
外科学 | 7778篇 |
综合类 | 344篇 |
一般理论 | 17篇 |
预防医学 | 6139篇 |
眼科学 | 1050篇 |
药学 | 4290篇 |
中国医学 | 194篇 |
肿瘤学 | 3257篇 |
出版年
2023年 | 353篇 |
2022年 | 868篇 |
2021年 | 1874篇 |
2020年 | 971篇 |
2019年 | 1559篇 |
2018年 | 3377篇 |
2017年 | 2032篇 |
2016年 | 1434篇 |
2015年 | 1419篇 |
2014年 | 2108篇 |
2013年 | 2864篇 |
2012年 | 4115篇 |
2011年 | 4271篇 |
2010年 | 2441篇 |
2009年 | 2143篇 |
2008年 | 3457篇 |
2007年 | 3496篇 |
2006年 | 3320篇 |
2005年 | 3342篇 |
2004年 | 3081篇 |
2003年 | 2907篇 |
2002年 | 2747篇 |
2001年 | 1455篇 |
2000年 | 1542篇 |
1999年 | 1271篇 |
1998年 | 523篇 |
1997年 | 354篇 |
1996年 | 341篇 |
1995年 | 285篇 |
1994年 | 248篇 |
1993年 | 238篇 |
1992年 | 612篇 |
1991年 | 492篇 |
1990年 | 491篇 |
1989年 | 427篇 |
1988年 | 380篇 |
1987年 | 402篇 |
1986年 | 350篇 |
1985年 | 310篇 |
1984年 | 224篇 |
1983年 | 186篇 |
1979年 | 173篇 |
1978年 | 152篇 |
1977年 | 129篇 |
1976年 | 127篇 |
1975年 | 143篇 |
1974年 | 135篇 |
1973年 | 146篇 |
1972年 | 143篇 |
1971年 | 133篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
981.
Judit Müller Miklós Garami Tamás Constantin Marianne Schmidt György Fekete Gábor Kovács 《Pediatric hematology and oncology》2013,30(4):277-284
The aim of this retrospective study was to evaluate the clinical effectiveness of meropenem in immunocompromised children. Between January 1998 and December 2002 in the hemato-oncological units of our hospital meropenem was used in 87 febrile events diagnosed in 55 patients, and 328 bacterial cultures were evaluated. Microorganisms were detected and identified in 64 of the 328 hemocultures; there was a predominance of gram-positive strains (67%). In 49.4% the infection was documented microbiologically. In 16 additional cases the infection was proven clinically and 32.2% of the episodes were considered to be fever of unknown origin. The success rate of the meropenem therapy—excluding the proven fungal or coagulase-negative Staphylococcus infections—was 72.9% and for the whole cohort 49.4%. The results demonstrate that meropenem is effective and well-tolerated when used for the treatment of neutropenic cancer children. 相似文献
982.
Péter Perge András M. Boros Endre Zima László Gellér Gábor Széplaki 《Scandinavian cardiovascular journal : SCJ》2013,47(5):250-255
AbstractObjectives: Changes in the levels of serum creatinine and N-terminal of prohormone brain natriuretic peptide (NT-proBNP) are useful risk markers after cardiac resynchronization therapy (CRT). The diagnostic value of changes in serum uric acid levels has been established in chronic heart failure, but no data are available on the prognostic value of hyperuricemia in a CRT population. Design: We measured markers of renal function [creatinine, blood urea nitrogen (BUN) and uric acid] and NT-proBNP levels of 129 heart failure patients undergoing CRT in a prospective, observational study. The 5-year all-cause mortality and the 6-month clinical response (≥ 15% increase in the left ventricular ejection fraction) were considered as study end points. Results: In multivariable analyses, the uric acid was found to be a statistically significant predictor of the outcome. Uric acid levels exceeding 386?mmol/L before CRT increased the chances of mortality [n?=?55, hazard ratio?=?2.39 (1.30-4.39), p?<?0.01] and poor clinical response [n?=?37, odds ratio?=?2.89 (1.22-6.87), p?=?0.01] independently of serum NT-proBNP and other factors. Conclusions: Elevated uric acid concentrations in patients with CRT are associated with an increased risk of mortality and poor clinical response independently of the NT-proBNP levels and other relevant clinical factors. 相似文献
983.
984.
M. Jesús Cerecedo Pérez Margarita Tovar Bobo Aurora Rozadilla Arias 《Atencion primaria / Sociedad Espa?ola de Medicina de Familia y Comunitaria》2013,45(10):536-540
The power of medicine has lately enhanced the idea of medicalizing any aspects of life that can be perceived as medical problems. Medicine sometimes creates false needs and there is nowadays an increasing number of situations are medicalized with the pretext of treating fake diseases such as spring fatigue, shyness o natural biological processes like menopause.Despite the better life conditions, we now attend more people that complain about discomfort that may have more to do with «feeling sick» than with authentic disease. There is an endless list: sadness, hyperactive children, anorexia, bulimia, vigorexia or problematic teenagers, amongst others. In this article we revise some interventions that, contribute to promote these situations also from the own doctor's office. Everyday adversity acquires today the status of disease, hence the remarkable increase in these consultations in the diverse sanitary services. 相似文献
985.
986.
987.
988.
989.
Sarah Heili Frades María del Pilar Carballosa de Miguel Alba Naya Prieto Marina Galdeano Lozano Xavier Mate García Ignacio Mahillo Fernández Itziar Fernández Ormaechea Laura Álvarez Suárez Farah Ezzine de Blas María José Checa Venegas Nicolás González Mangado Germán Peces Barba 《Archivos de bronconeumologia》2019,55(12):634-641
IntroductionHistorically, it has been assumed that Intermediate Respiratory Care Units (IRCU) were efficient, because they saved costs by reducing the number of admissions to intensive care units (ICU), and effective, because they specialized in respiratory diseases.MethodsThe number of IRCU admissions and mortality rate, historically and in 2016, were evaluated. For 2016, the grouped Related Diagnostic Groups (DRGs) were also described, and the savings achieved under all budgetary headings by avoiding UCI stays were calculated. A multivariate analysis was performed to associate costs with mean weights and complexity, and multiple logistic regression was performed on all patients admitted from 2004 to 2017 to describe the variables associated with mortality in our unit.ResultsAn IRCU generates savings of €500,000/year by reducing length of ICU stay. Analysis of the 2016 cohort shows that costs correlate with mean weight and mortality, and consequently complexity. The multivariate logistic regression analysis of the 2004–2017 cohort found respiratory frequency, leukopenia, anemia, hyperkalemia, and acidosis to be the variables best associated with mortality. The area under the curve for the logistic model was 0.75.ConclusionThe IRCU analyzed in our study was efficient in terms of ‘avoided costs’ and savings associated with complexity. Our results suggest that IRCUs have a lower mortality rate than other similar units, and are therefore a safe environment for patients. 相似文献
990.
Nuno A. G. Gra?a Luis Gaspar David M. Costa Inês Loureiro Paul Kong Thoo-Lin Isbaal Ramos Meritxell Roura Alain Pruvost Ian K. Pemberton Hadjer Loukil Jane MacDougall Joana Tavares Anabela Cordeiro-da-Silva 《Antimicrobial agents and chemotherapy》2016,60(4):2532-2536
Current treatments for African trypanosomiasis are either toxic, costly, difficult to administer, or prone to elicit resistance. This study evaluated the activity of bisnaphthalimidopropyl (BNIP) derivatives against Trypanosoma brucei. BNIPDiaminobutane (BNIPDabut), the most active of these compounds, showed in vitro inhibition in the single-unit nanomolar range, similar to the activity in the reference drug pentamidine, and presented low toxicity and adequate metabolic stability. Additionally, using a murine model of acute infection and live imaging, a significant decrease in parasite load in BNIPDabut-treated mice was observed. However, cure was not achieved. BNIPDabut constitutes a new scaffold for antitrypanosomal drugs that deserves further consideration. 相似文献